FdaApplication
NDA 207534
Identifiers
- fda_app_no: NDA207534
Properties
| Property | Value |
|---|---|
| applicant_name | ADAMIS PHARMACEUTICALS CORP |
| application_type | NDA |
| approval_date | 2017-06-15 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| SYMJEPI | EPINEPHRINE | 0.15MG/0.3ML (0.15MG/0.3ML) | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS |
| SYMJEPI | EPINEPHRINE | 0.3MG/0.3ML (0.3MG/0.3ML) | SOLUTION;INTRAMUSCULAR, SUBCUTANEOUS |
2 products